메뉴 건너뛰기




Volumn 94, Issue 2, 2013, Pages 184-189

FDG-PET in the evaluation of myeloma in 2012

Author keywords

FDG; Multiple myeloma; PET CT; Solitary plasmacytoma; Therapeutic evaluation

Indexed keywords

FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18;

EID: 84878315027     PISSN: None     EISSN: 22115684     Source Type: Journal    
DOI: 10.1016/j.diii.2012.12.006     Document Type: Short Survey
Times cited : (6)

References (19)
  • 1
    • 66149139452 scopus 로고    scopus 로고
    • From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors
    • Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009;50(1):122S - 50S
    • (2009) J Nucl Med , vol.50 , Issue.1
    • Wahl, R.L.1    Jacene, H.2    Kasamon, Y.3    Lodge, M.A.4
  • 3
    • 40849085779 scopus 로고    scopus 로고
    • Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma
    • Bodet-Milin C, Kraeber-Bodéré F, Moreau P, Campion L, Dupas B, Le Gouill S. Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma. Haematologica 2008;93(3):471 - 2
    • (2008) Haematologica , vol.93 , pp. 3471-3472
    • Bodet-Milin, C.1    Kraeber-Bodéré, F.2    Moreau, P.3    Campion, L.4    Dupas Le Gouill, B.S.5
  • 4
    • 0016804136 scopus 로고
    • A clinical staging system for multiple myeloma: Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
    • Durie BG, Salmon SE. A clinical staging system for multiple myeloma: Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975;36:842 - 54
    • (1975) Cancer , vol.36 , pp. 842-854
    • Durie, B.G.1    Salmon, S.E.2
  • 5
    • 33746515610 scopus 로고    scopus 로고
    • The role of anatomic and functional staging in myeloma: Description of Durie/Salmon plus staging system
    • Durie BG. The role of anatomic and functional staging in myeloma: Description of Durie/Salmon plus staging system. Eur J Cancer 2006;42:1539 - 43
    • (2006) Eur J Cancer , vol.42 , pp. 1539-1543
    • Durie, B.G.1
  • 6
    • 79956001465 scopus 로고    scopus 로고
    • Consensus recommendations for standard investigative workup: Report of the International Myeloma Workshop Consensus Panel 3
    • Dimopoulos M, Kyle R, Fermand JP, Rajkumar SV, San Miguel J, Chanan-Khan A, et al. Consensus recommendations for standard investigative workup: Report of the International Myeloma Workshop Consensus Panel 3. Blood 2011;117(18):4701 - 5
    • (2011) Blood , vol.117 , Issue.18 , pp. 4701-4705
    • Dimopoulos, M.1    Kyle, R.2    Fermand, J.P.3    Rajkumar, S.V.4    San Miguel, J.5    Chanan-Khan, A.6
  • 7
    • 0346363760 scopus 로고    scopus 로고
    • The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma
    • Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, et al. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 2003;349:2483 - 94
    • (2003) N Engl J Med , vol.349 , pp. 2483-2494
    • Tian, E.1    Zhan, F.2    Walker, R.3    Rasmussen, E.4    Ma, Y.5    Barlogie, B.6
  • 8
    • 34047195753 scopus 로고    scopus 로고
    • Magnetic resonance imaging in multiple myeloma: Diagnostic and clinical implications
    • Walker R, Barlogie B, Haessler J, et al. Magnetic resonance imaging in multiple myeloma: Diagnostic and clinical implications. J Clin Oncol 2007;25:1121 - 8
    • (2007) J Clin Oncol , vol.25 , pp. 1121-1128
    • Walker, R.1    Barlogie, B.2    Haessler, J.3
  • 9
    • 48749110375 scopus 로고    scopus 로고
    • FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma
    • Salaun PY, Gastinne T, Frampas E, Bodet-Milin C, Moreau P, Bodéré-Kraeber F. FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma. Haematologica 2008;93(8):1269 - 71
    • (2008) Haematologica , vol.93 , Issue.8 , pp. 1269-1271
    • Salaun, P.Y.1    Gastinne, T.2    Frampas, E.3    Bodet-Milin, C.4    Moreau, P.5    Bodéré-Kraeber, F.6
  • 12
    • 1642346016 scopus 로고    scopus 로고
    • Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma
    • Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E, et al. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol 2004;124:717 - 26
    • (2004) Br J Haematol , vol.124 , pp. 717-726
    • Soutar, R.1    Lucraft, H.2    Jackson, G.3    Reece, A.4    Bird, J.5    Low, E.6
  • 14
    • 33846916461 scopus 로고    scopus 로고
    • A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma
    • Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O, et al. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica 2007;92:50 - 5
    • (2007) Haematologica , vol.92 , pp. 50-55
    • Zamagni, E.1    Nanni, C.2    Patriarca, F.3    Englaro, E.4    Castellucci, P.5    Geatti, O.6
  • 16
    • 70349231349 scopus 로고    scopus 로고
    • F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
    • Bartel TB, Haessler J, Brown TL, Shaughnessy Jr JD, van Rhee F, Anaissie E, et al. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood 2009;114(10):2068 - 76
    • (2009) Blood , vol.114 , Issue.10 , pp. 2068-2076
    • Bartel, T.B.1    Haessler, J.2    Brown, T.L.3    Shaughnessy Jr., J.D.4    Van Rhee, F.5    Anaissie, E.6
  • 17
    • 82955189267 scopus 로고    scopus 로고
    • Prognostic relevance of 18-F FDG PET-CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation
    • Zamagni E, Patriarca F, Nanni C, Zannetti B, Englaro E, Pezzi A, et al. Prognostic relevance of 18-F FDG PET-CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation. Blood 2011;118(23):5989 - 95
    • (2011) Blood , vol.118 , Issue.23 , pp. 5989-5995
    • Zamagni, E.1    Patriarca, F.2    Nanni, C.3    Zannetti, B.4    Englaro, E.5    Pezzi, A.6
  • 19
    • 83055186738 scopus 로고    scopus 로고
    • PET-CT in MM: A new definition of CR
    • Moreau P. PET-CT in MM: A new definition of CR. Blood 2011;118(23):5984 - 5
    • (2011) Blood , vol.23 , Issue.118 , pp. 5984-5985
    • Moreau, P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.